GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...
After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...
The British pharma is making what it calls its largest U.S. manufacturing investment. Elsewhere, AbbVie expanded a ...
Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...
Shares of GSK PLC GSK inched up 0.52% to £14.56 Thursday, on what proved to be an all-around positive trading session for ...
“These promising data add to the evidence supporting GSK’s RSV vaccine and could help expand protection to more adults at ...
GSK (NYSE:GSK) continued losses for a seventh straight session as the stock closed 0.61% lower, at $37.51 on Friday.  The ...
GSK is pumping £50 million (about $65 million) into a five-year collaboration with the University of Cambridge and Cambridge ...
Shares of GSK PLC GSK inched down 0.72% to £14.54 Tuesday, on what proved to be an all-around dismal trading session for ...
GSK has announced a new collaboration with local university and medical researchers, while Editas Medicine has a deal to ...
GSK said it is making its largest manufacturing investment in the US yet, allocating $800 million to upgrade its vaccine ...